Incidence of non-alcoholic fatty liver disease inantiretroviral therapy-naïve patients living with HIV whostart a regimen with DTG/ABC/3TC compared to thosewho start BIC/FTC/TAF at 48-week follow-up at theHospital de Infectología CMN “La Raza”: a preliminary analysis.
Cano-Díaz Ana Luz1, Pérez-Barragán Edgar1, Triana-González Salma1, Salinas-Velázquez Gloria Elizabeth2, Rodríguez-Evaristo Mara Soraya3, Mata-Marín José Antonio1, Gaytán-Martínez Jesús Enrique1. Incidence of non-alcoholic fatty liver disease in antiretroviral therapy-naïve patients living with HIV who start a regimen with DTG/ABC/3TC compared to those who start BIC/FTC/TAF at